189 related articles for article (PubMed ID: 16763275)
21. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
[TBL] [Abstract][Full Text] [Related]
22. [The present situation of neoadjuvant therapy for head and neck carcinoma].
Rikimaru F; Tomita K
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1535-7. PubMed ID: 17940367
[TBL] [Abstract][Full Text] [Related]
23. Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck.
Matzinger O; Zouhair A; Mirimanoff RO; Ozsahin M
Clin Oncol (R Coll Radiol); 2009 Sep; 21(7):525-31. PubMed ID: 19535232
[TBL] [Abstract][Full Text] [Related]
24. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
Roman E; Raez LE; Santos ES
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
[TBL] [Abstract][Full Text] [Related]
25. Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancer.
Rivera F; Eugenia Vega-Villegas M; López C; Francisca López-Brea M; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Hinojo C; Márquez R; Angel Alonso-Bermejo M; Salcedo M; Blanco Y; Vega N; López-Tarruella S; Sanz-Ortiz J
Acta Oncol; 2008; 47(8):1584-9. PubMed ID: 18607841
[TBL] [Abstract][Full Text] [Related]
26. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
27. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Watai K
Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
[TBL] [Abstract][Full Text] [Related]
28. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
29. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
30. Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer.
Posner M; Vermorken JB
Semin Oncol; 2008 Jun; 35(3):221-8. PubMed ID: 18544437
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin plus radiation therapy.
Wheeler RH; Spencer S
J Infus Chemother; 1995; 5(2):61-6. PubMed ID: 8521236
[TBL] [Abstract][Full Text] [Related]
32. Controversies in the multimodality management of head and neck cancer.
Thomas CR; Taylor SG
Hematol Oncol Clin North Am; 1991 Aug; 5(4):769-81. PubMed ID: 1890066
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Colevas AD
J Clin Oncol; 2006 Jun; 24(17):2644-52. PubMed ID: 16763278
[TBL] [Abstract][Full Text] [Related]
34. Revisiting induction chemotherapy for head and neck cancer.
Argiris A; Jayaram P; Pichardo D
Oncology (Williston Park); 2005 May; 19(6):759-70. PubMed ID: 15971451
[TBL] [Abstract][Full Text] [Related]
35. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J
Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953
[TBL] [Abstract][Full Text] [Related]
36. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
Forastiere AA
J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
[No Abstract] [Full Text] [Related]
37. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice?
Harari PM
J Clin Oncol; 1997 May; 15(5):2050-5. PubMed ID: 9164217
[TBL] [Abstract][Full Text] [Related]
38. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
Rodriguez CP; Adelstein DJ; Rybicki LA; Saxton JP; Lorenz RR; Wood BG; Strome M; Esclamado RM; Lavertu P; Carroll MA
Head Neck; 2008 Dec; 30(12):1535-42. PubMed ID: 18704968
[TBL] [Abstract][Full Text] [Related]
39. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
Murdoch D
Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
[TBL] [Abstract][Full Text] [Related]
40. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
Tahara M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]